6 recent orthobiologics updates

From company acquisitions to FDA nods, here are six key updates in orthobiologics since Oct. 4.

Advertisement

1. RTI Surgical, a contract development and manufacturing organization, plans to acquire Collagen Solutions.

2. Tetrous, a start-up focused on bone-to-tendon healing following orthopedic surgery, has earned a fourth patent related to its EnFix family of demineralized cortical bone fiber implants. 

3. Bone Biologics appointed Phillip Meikle to its board of directors. 

4. CytexOrtho has earned FDA approval to begin a clinical trial evaluating the safety and efficacy of its absorbable hip implant in human patients.

5. Biologics company Theradaptive’s lead therapeutic, OsteoAdapt SP, has been featured in a preclinical spinal fusion study published in Spine, a prominent, peer-reviewed publication for spinal surgeons.

6. Acuitive Technologies earned FDA clearance for the Citrepore bioactive bone filler.

Advertisement

Next Up in Biologics

  • Regenerative medicine company Auragens has opened an orthobiologics division.  Orthopedic surgeon Abdiel Ortiz, MD, will lead the new division, which…

  • So far this year, medtech companies and academic institutions are making key strides in spine biologics. From new product launches…

Advertisement

Comments are closed.